Urinalysis Solutions

Learn about our urinalysis solutions.

Hematology Solutions

Learn about our hematology solutions.

Personalized Medicine Solutions

Learn about our personalized medicine solutions.

About Iris International

At IRIS, we are dedicated to the relentless development of transformational technologies. Concentrated in urinalysis, hematology, and predictive, personalized medicine, our automated solutions accelerate diagnostic confidence and laboratory productivity.

News

Sep

2012

IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC

IRIS has been asked to speak at AdvaMedDx's Hill Briefing on "The Role of Advanced Diagnostics in Cancer Care" and the Eighth Annual Summit of the Prostate Health Education Network, Inc. Read More »

Sep

2012

IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share

IRIS International, Inc. (Nasdaq:IRIS) announced that it has entered into a definitive merger agreement under which Danaher Corporation (NYSE:DHR) will acquire IRIS International for $19.50 per share in cash. Read More »